Cargando…

Inducible expression of cancer-testis antigens in human prostate cancer

Immune tolerance to self-antigens can limit robust anti-tumor immune responses in the use of tumor vaccines. Expression of novel tumor associated antigens can improve immune recognition and lysis of tumor cells. The cancer-testis antigen (CTA) family of proteins has been hypothesized to be an ideal...

Descripción completa

Detalles Bibliográficos
Autores principales:	Heninger, Erika, Krueger, Timothy E.G., Thiede, Stephanie M., Sperger, Jamie M., Byers, Brianna L., Kircher, Madison R., Kosoff, David, Yang, Bing, Jarrard, David F., McNeel, Douglas G., Lang, Joshua M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2016
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5341296/ https://www.ncbi.nlm.nih.gov/pubmed/27769045 http://dx.doi.org/10.18632/oncotarget.12711

Ejemplares similares

Inducible expression of antigen processing and antigen presentation molecules and cancer testis antigens in human prostate cancer
por: Heninger, Erika, et al.
Publicado: (2015)

Reversible epigenetic alterations regulate class I HLA loss in prostate cancer
por: Rodems, Tamara S., et al.
Publicado: (2022)

The SSX Family of Cancer-Testis Antigens as Target Proteins for Tumor Therapy
por: Smith, Heath A., et al.
Publicado: (2010)

Integrated analysis of the tumor microenvironment using a reconfigurable microfluidic cell culture platform
por: Sethakorn, Nan, et al.
Publicado: (2022)

Immune profiling of the bone marrow microenvironment in patients with high-risk localized prostate cancer
por: Heninger, Erika, et al.
Publicado: (2020)

Live cell molecular analysis of primary prostate cancer organoids identifies persistent androgen receptor signaling
por: Heninger, Erika, et al.
Publicado: (2021)

SEEMLIS: a flexible semi-automated method for enrichment of methylated DNA from low-input samples
por: Rodems, Tamara S., et al.
Publicado: (2022)

Cancer testis antigen and immunotherapy
por: Krishnadas, Deepa Kolaseri, et al.
Publicado: (2013)

Augmenting Antitumor Immune Responses with Epigenetic Modifying Agents
por: Héninger, Erika, et al.
Publicado: (2015)

Fresh tissue procurement and preparation for multicompartment and multimodal analysis of the prostate tumor microenvironment
por: Vitek, Ross A., et al.
Publicado: (2022)

Molecular analysis of antigen presentation machinery in circulating tumor cells from renal cell carcinoma and prostate cancer
por: Lang, Joshua M, et al.
Publicado: (2013)

B lymphocyte mediated antigen presentation of plasmid DNA
por: Colluru, Viswa Teja, et al.
Publicado: (2013)

TCR diversity – a universal cancer immunotherapy biomarker?
por: McNeel, Douglas G.
Publicado: (2016)

Sipuleucel-T: immunotherapy for advanced prostate cancer
por: Olson, Brian M, et al.
Publicado: (2011)

B cells require licensing by dendritic cells to serve as primary antigen-presenting cells for plasmid DNA
por: Rastogi, Ichwaku, et al.
Publicado: (2023)

B lymphocytes as direct antigen-presenting cells for anti-tumor DNA vaccines
por: Colluru, Viswa Teja, et al.
Publicado: (2016)

Presence of antigen-specific somatic allelic mutations and splice variants do not predict for immunological response to genetic vaccination
por: Becker, Jordan T, et al.
Publicado: (2013)

Advancing Treatment of Bone Metastases through Novel Translational Approaches Targeting the Bone Microenvironment
por: Sethakorn, Nan, et al.
Publicado: (2022)

Cancer/testis antigens (CTAs) expression in resected lung cancer
por: Jin, Shi, et al.
Publicado: (2018)

Targeting cancer testis antigens in synovial sarcoma
por: Mitchell, Geoffrey, et al.
Publicado: (2021)

Cancer-testis antigen expression and immunogenicity in AL amyloidosis
por: Rosenzweig, M A, et al.
Publicado: (2012)

Pretreatment antigen-specific immunity and regulation - association with subsequent immune response to anti-tumor DNA vaccination
por: Johnson, Laura E., et al.
Publicado: (2017)

SSX expression and function in prostate cancer
por: Bloom, Jordan E, et al.
Publicado: (2013)

Biology of Cancer-Testis Antigens and Their Therapeutic Implications in Cancer
por: Nin, Dawn Sijin, et al.
Publicado: (2023)

Vaccines as treatments for prostate cancer
por: Rastogi, Ichwaku, et al.
Publicado: (2023)

Cancer/testis antigens and obligate participation in multiple hallmarks of cancer: an update
por: Mooney, Steven M, et al.
Publicado: (2016)

Cancer testis antigens expression in mesothelioma: role of DNA methylation and bioimmunotherapeutic implications
por: Sigalotti, L, et al.
Publicado: (2002)

PARP inhibitors in metastatic prostate cancer
por: Taylor, Amy K., et al.
Publicado: (2023)

SSX2 regulates focal adhesion but does not drive the epithelial to mesenchymal transition in prostate cancer
por: Bloom, Jordan E., et al.
Publicado: (2016)

Pattern of cancer/testis antigen expression in lung cancer patients
por: KIM, YEONG-DAE, et al.
Publicado: (2012)

Cancer testis antigens: A new paradigm for cancer therapy
por: Suri, Anil, et al.
Publicado: (2012)

Expression of cancer–testis antigens in esophageal cancer and their progress in immunotherapy
por: Zhang, Yujie, et al.
Publicado: (2019)

Characterization of Cancer/Testis Antigens as Prognostic Markers of Ovarian Cancer
por: Vlasenkova, Ramilia, et al.
Publicado: (2023)

Engineering Cancer/Testis Antigens With Reversible S-Cationization to Evaluate Antigen Spreading
por: Miyamoto, Ai, et al.
Publicado: (2022)

Integrative Discovery of Epigenetically Derepressed Cancer Testis Antigens in NSCLC
por: Glazer, Chad A., et al.
Publicado: (2009)

Immunotherapy in Multiple Myeloma Using Cancer-Testis Antigens
por: Ghafouri-Fard, Soudeh, et al.
Publicado: (2015)

Oncogenic cancer/testis antigens: prime candidates for immunotherapy
por: Gjerstorff, Morten F., et al.
Publicado: (2015)

CETN1 is a cancer testis antigen with expression in prostate and pancreatic cancers
por: Kim, John J, et al.
Publicado: (2013)

Epitope optimization of a DNA vaccine targeting SSX-2 leads to PD-1 upregulation on antigen-specific CD8 T cells and PD-L1 upregulation on tumor cells
por: Rekoske, Brian, et al.
Publicado: (2013)

NY-ESO-1 Cancer Testis Antigen Demonstrates High Immunogenicity in Triple Negative Breast Cancer
por: Ademuyiwa, Foluso O., et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_h6bu5e2luireu9ve51ni6m0e7j